The evidence base for AbilityScore®

A measurement tool earns trust not by claim but by the evidence woven through its design, validation and real-world use — here is where AbilityScore® stands.

In short

The evidence base for AbilityScore® rests on three pillars: a structured, clinician-administered design grounded in established developmental science; validation work documented across 12 validated studies; and a very large real-world dataset of 2.5 billion+ data points drawn from 25 million+ therapy sessions and 4.95 lakh+ families served. It is registered as a CDSCO Class B Software as a Medical Device (SaMD) and is protected by 16+ WIPO PCT patents. Importantly, AbilityScore® is a clinician-administered structured assessment — never a self-scoring app — and its evidence supports its use as one part of holistic clinical judgement.

The science behind the instrument

AbilityScore® is built to map a child's abilities across multiple developmental domains rather than reducing a child to a single number or label. Its evidence base draws on the convergent foundations of mainstream developmental surveillance and measurement: the construct of profiling strengths and support-needs across language, social-emotional, motor, cognitive and adaptive domains aligns with the framing used by the WHO, the American Academy of Pediatrics and the CDC. The instrument's validation programme — reflected in the consortium's 12 validated studies — examines the qualities that matter for any measurement tool: consistency of administration, alignment with recognised developmental constructs, and usefulness in guiding individualised therapy planning. The scale of the underlying dataset (2.5 billion+ data points across 25 million+ sessions and 70+ centres in 4 states) supports continued refinement, while protecting the principle that scores inform, but never replace, a qualified clinician's interpretation. The internal scoring logic, item weighting and thresholds are not disclosed; the evidence speaks to the tool's design rigour, regulatory standing and clinical utility, not to a publicly reverse-engineerable formula.

How the evidence is governed

For a researcher or clinician evaluating AbilityScore®, the relevant assurances are its CDSCO Class B SaMD registration — placing it within India's medical-device regulatory framework — and the body of validated studies and patent filings (16+ WIPO PCT) that document its development. Evidence here should be read as supporting a structured, clinician-led assessment process, not as a standalone diagnostic test. AbilityScore® is administered, interpreted and contextualised within a centre by qualified clinicians who integrate it with history, observation and family priorities.

The Pinnacle way

A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never from an app, a form or a score in isolation. To understand how the instrument is administered and what it measures, see how the AbilityScore® is calculated, and explore how findings translate into individualised support such as speech therapy.

Trusted sources

WHO Nurturing Care Framework and WHO developmental guidance on early childhood; American Academy of Pediatrics and HealthyChildren on developmental surveillance and screening; CDC developmental-milestone resources; and the Rehabilitation Council of India on standards for assessment practice — all paraphrased.

Next step — If you are a researcher or clinician seeking to evaluate or collaborate on the AbilityScore® evidence base, reach out to explore a research partnership with the SETU Consortium.

This is general information, not a diagnosis — individual assessment and diagnosis require an appropriately qualified healthcare professional.